DHC Fundamental Analysis - DIVERSIFIED HEALTHCARE TRUST

Fundamental Rating

Taking everything into account, DHC scores 2 out of 10 in our fundamental rating. DHC was compared to 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of DHC have multiple concerns. DHC has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

DHC had negative earnings in the past year.

In the past year DHC had a positive cash flow from operations.

In the past 5 years DHC reported 4 times negative net income.

The reported operating cash flow has been mixed in the past 5 years: DHC reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of DHC (-5.86%) is worse than 85.27% of its industry peers.

Looking at the Return On Equity, with a value of -15.04%, DHC is doing worse than 81.40% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-5.86%
ROE	-15.04%
ROIC	N/A

ROA(3y)-4.29%

ROA(5y)-2.48%

ROE(3y)-10.69%

ROE(5y)-6.22%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 17.75%, DHC is not doing good in the industry: 93.02% of the companies in the same industry are doing better.

DHC's Gross Margin has declined in the last couple of years.

DHC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	17.75%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.33%

GM growth 5Y-20.05%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DHC does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for DHC has been increased compared to 1 year ago.

DHC has more shares outstanding than it did 5 years ago.

DHC has a worse debt/assets ratio than last year.

2.2 Solvency

DHC has an Altman-Z score of -0.24. This is a bad value and indicates that DHC is not financially healthy and even has some risk of bankruptcy.

DHC's Altman-Z score of -0.24 is on the low side compared to the rest of the industry. DHC is outperformed by 79.07% of its industry peers.

DHC has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.

The Debt to Equity ratio of DHC (1.44) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	1.44
Debt/FCF	N/A
Altman-Z	-0.24

ROIC/WACCN/A

WACC6.56%

2.3 Liquidity

DHC has a Current Ratio of 7.40. This indicates that DHC is financially healthy and has no problem in meeting its short term obligations.

DHC has a Current ratio of 7.40. This is amongst the best in the industry. DHC outperforms 96.90% of its industry peers.

A Quick Ratio of 7.40 indicates that DHC has no problem at all paying its short term obligations.

DHC has a better Quick ratio (7.40) than 96.90% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	7.4
Quick Ratio	7.4

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.62% over the past year.

DHC shows a small growth in Revenue. In the last year, the Revenue has grown by 5.33%.

DHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.53% yearly.

EPS 1Y (TTM)39.62%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%113.89%

Revenue 1Y (TTM)5.33%

Revenue growth 3Y2.63%

Revenue growth 5Y7.53%

Sales Q2Q%4.34%

3.2 Future

DHC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.50% yearly.

The Revenue is expected to grow by 4.05% on average over the next years.

EPS Next Y40.36%

EPS Next 2Y13.5%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year3.6%

Revenue Next 2Y4.05%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

DHC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DHC. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DHC is on the same level as its industry peers.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	14.1

4.3 Compensation for Growth

A more expensive valuation may be justified as DHC's earnings are expected to grow with 13.50% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y13.5%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.16%, DHC has a reasonable but not impressive dividend return.

With a Dividend Yield of 1.16, DHC pays less dividend than the industry average, which is at 6.77. 92.25% of the companies listed in the same industry pay a better dividend than DHC!

Compared to an average S&P500 Dividend Yield of 2.40, DHC's dividend is way lower than the S&P500 average.

		Industry Rank	Sector Rank
Dividend Yield	1.16%

5.2 History

The dividend of DHC decreases each year by -45.60%.

DHC has paid a dividend for at least 10 years, which is a reliable track record.

DHC has not decreased its dividend in the last 3 years.

Dividend Growth(5Y)-45.6%

Div Incr Years0

Div Non Decr Years3

5.3 Sustainability

The earnings of DHC are negative and hence is the payout ratio. DHC will probably not be able to sustain this dividend level.

DP-3.29%

EPS Next 2Y13.5%

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DIVERSIFIED HEALTHCARE TRUST

NASDAQ:DHC (6/18/2025, 8:00:00 PM)

After market: 3.69 0 (0%)

3.69

+0.08 (+2.22%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)05-05 2025-05-05/amc

Earnings (Next)07-30 2025-07-30/amc

Inst Owners77.49%

Inst Owner Change2.44%

Ins Owners0.41%

Ins Owner ChangeN/A

Market Cap890.21M

Analysts48

Price Target3.83 (3.79%)

Short Float %2.32%

Short Ratio6.11

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.16%

Yearly Dividend0.04

Dividend Growth(5Y)-45.6%

DP-3.29%

Div Incr Years0

Div Non Decr Years3

Ex-Date04-22 2025-04-22 (0.01)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)49.8%

Min EPS beat(2)-22.91%

Max EPS beat(2)122.5%

EPS beat(4)2

Avg EPS beat(4)45.86%

Min EPS beat(4)-23.76%

Max EPS beat(4)122.5%

EPS beat(8)3

Avg EPS beat(8)21.36%

EPS beat(12)4

Avg EPS beat(12)5.31%

EPS beat(16)5

Avg EPS beat(16)-4.23%

Revenue beat(2)1

Avg Revenue beat(2)0.64%

Min Revenue beat(2)-0.04%

Max Revenue beat(2)1.32%

Revenue beat(4)1

Avg Revenue beat(4)-0.58%

Min Revenue beat(4)-2.43%

Max Revenue beat(4)1.32%

Revenue beat(8)2

Avg Revenue beat(8)-0.78%

Revenue beat(12)4

Avg Revenue beat(12)-0.58%

Revenue beat(16)4

Avg Revenue beat(16)-1.37%

PT rev (1m)15.38%

PT rev (3m)87.5%

EPS NQ rev (1m)-4.76%

EPS NQ rev (3m)4.35%

EPS NY rev (1m)0%

EPS NY rev (3m)32.61%

Revenue NQ rev (1m)0.13%

Revenue NQ rev (3m)2.37%

Revenue NY rev (1m)-1.21%

Revenue NY rev (3m)-0.83%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.59
P/FCF	N/A
P/OCF	11.08
P/B	0.46
P/tB	0.46
EV/EBITDA	14.1

EPS(TTM)-0.64

EYN/A

EPS(NY)-0.75

Fwd EYN/A

FCF(TTM)-0.47

FCFYN/A

OCF(TTM)0.33

OCFY9.03%

SpS6.27

BVpS8.07

TBVpS8.07

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-5.86%
ROE	-15.04%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	17.75%
FCFM	N/A

ROA(3y)-4.29%

ROA(5y)-2.48%

ROE(3y)-10.69%

ROE(5y)-6.22%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.33%

GM growth 5Y-20.05%

F-Score7

Asset Turnover0.3

Health

		Industry Rank	Sector Rank
Debt/Equity	1.44
Debt/FCF	N/A
Debt/EBITDA	11.65
Cap/Depr	68.74%
Cap/Sales	12.88%
Interest Coverage	N/A
Cash Conversion	33.45%
Profit Quality	N/A
Current Ratio	7.4
Quick Ratio	7.4
Altman-Z	-0.24

F-Score7

WACC6.56%

ROIC/WACCN/A

Cap/Depr(3y)103.34%

Cap/Depr(5y)92.72%

Cap/Sales(3y)19.78%

Cap/Sales(5y)17.46%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)39.62%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%113.89%

EPS Next Y40.36%

EPS Next 2Y13.5%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)5.33%

Revenue growth 3Y2.63%

Revenue growth 5Y7.53%

Sales Q2Q%4.34%

Revenue Next Year3.6%

Revenue Next 2Y4.05%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y44.97%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year369.96%

EBIT Next 3Y72.02%

EBIT Next 5YN/A

FCF growth 1Y71.86%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y397.18%

OCF growth 3YN/A

OCF growth 5Y-15.84%

DIVERSIFIED HEALTHCARE TRUST (DHC) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens